Caracterização molecular das enzimas glutationa stransferase (genes gstt1, gstm1 e gstp1) em pacientes com malária por plasmodium vivax.

Abstract

Plasmodium vivax threatens ~40% of the world s population, with a wide spectrum of asymptomatic to severe clinical manifestations. Glutathione S-transferase (GST) gene polymorphisms have been shown to influence their ability to reduce oxidative stress. Using molecular tools we identified and compared GSTM1, GSTT1 and GSTP1 gene polymorphism in 175 uncomplicated (n=118) and severe (n=57) vivax patients. There were no differences in the frequency of GST alleles between uncomplicated and severe malaria. Nevertheless, a comparison of biochemical and hematological parameters in severe malaria, we observed patients with GSTM1 double-deletion had more platelets (p<0.04) suggesting a decreased risk of thrombocytopenia. In addition, patients with single and/or double deletion of GSTT1 and GSTM1 also had a reduced risk for thrombocytopenia (p<0.045, p<0.026, respectively) compared to wild type allele. In contrast, individuals with GSTP1 heterozygous or homozygous A313G mutation had an increased risk of jaundice (p<0.034, p<0.022) and anemia as observed with decreased RBCs (p<0.008), hemoglobin (p<0.019) and hematocrit (p<0.008) levels in serum. Our results, not only indicate a direct influence of GST polymorphism on biochemical parameters but also its diagnostic potential in assessing disease progression during clinical malaria.